ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0016525;negative regulation of angiogenesis;8.0;0.811012628672052;0.780506314336026;9.32314260294094;151.1079732353669;5.192106149009898;0.005057447875840929;0.6405245499179943;[SPARC, SERPINE1, FASLG, PRL, HHEX, STAB1, EMILIN1, HOXA5, CCR2, SEMA6A, HSPG2, DCN, COL4A2, HGS, CX3CR1, THBS2, THBS1, E2F2, SEMA4A, TGFB2, STAT1, PLK2, TIE1, KLF4, SULF1, PML, CXCL10, TEK, PF4]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[HMGB2, LRP2, GATA3, MEA1, GATA1, HOXA11, HOXA10, CTNNA1, PDGFRB, LHCGR, TGFB2, RRM1, BIK, INHBA, EIF2S2, ASPM, KITLG, SFRP2, NASP, MSH2, KIT, BCL2, BCL2L1]
GO:0034351;negative regulation of glial cell apoptotic process;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;104.32654737607098;7.697632086000634;0.003491715652880169;0.7686572628545723;[PRKCH, PRKCD, CCL2, DLL1]
GO:0061614;pri-miRNA transcription by RNA polymerase II;11.0;1.0;0.9324289523296623;9.628524252492122;587.6398479969114;7.57984905034425;0.019667776870928726;0.8200627852632958;[FOSL1, SPI1, KLF4, ETS1]
GO:0090330;regulation of platelet aggregation;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;97.23557350837086;6.943860283624253;0.0032543871389904074;0.7513499630073597;[LYN, CEACAM1, SYK, PDPN, PRKCD, CD9, PRKCQ, ALOX12]
GO:0008625;extrinsic apoptotic signaling pathway via death domain receptors;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;52.44533375847466;6.311337724880743;0.0017552981231601008;0.6736814700148209;[FASLG, TNF, CASP8AP2, SORT1, DAPK1, TNFRSF10B, BCL2]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, ICAM1, PYCARD, TNFSF11, TRIM25, PRKCH, PRKCB, BTK, PRKCQ, ADAM8, S100A9, S100A8, CARD11, TNFRSF11A, PRKCZ, NLRP3, S100A12, TGFB1, EIF2AK2, NFKB1, NFKB2, MYD88, CD40, ITGB2, CD36, CHUK, RIPK2, IL18, IRAK3, TRAF1, GREM1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0045648;positive regulation of erythrocyte differentiation;8.0;0.9326813400603323;0.8413406700301662;9.582004236857228;358.80145150428314;6.409777797693995;0.012008761681506467;0.7027963346592216;[MED1, STAT1, HMGB2, ISG15, INHBA, MAPK14, GATA1, ETS1, TAL1, INPP5D, NCKAP1L]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, PIK3C2A, ETS1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, CCR3, IL10, PPP1R16B, GHSR, ANXA1, ANXA3, PRKCB, GAB1, CYBB, SIRT1, F3, GREM1, IL1A, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, C3, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0032848;negative regulation of cellular pH reduction;12.0;0.9326813400603323;0.9144609826203107;9.589303539338841;367.95635365503233;9.777073627680469;0.012315168017615022;0.9481203125901445;[BCL2]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[CYFIP1, NRP1, CPNE5, CXCL16, RPS6KA1, AKT1, CD38, EDN1, AVPR1A, SFRP2, MAP1B, S100A9, S100A8, HBEGF, TAF9, LEF1, NEDD4L, PAK1, SFN, TGFB2, SYT2, FN1, IGF1, CXCL12, BCL2]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[MPL, RORA, PHB2, ETS1, SLC8A1, LOXL2, AQP1, ICAM1, EDNRA, PLAU, MYB, AKT1, POSTN, PRKCE, ACTN4, ATP1B1, CLDN3, ADAM8, ABCB4, PSEN2, TWIST1, DPP4, CCNB1, BRIP1, HMOX1, EGR1, TGFB2, TGFB1, VCAM1, CAV1, NR4A2, BMP2, CXCL12, BCL2, NOX4, CD24, SUV39H2, ALAS2, SUV39H1, ADM, ALAD, CD38, MYOCD, ADSL, EDN1, KCND2, MMP2, AGTRAP, SIRT1, CBFA2T3, TGFBR3, CCNA2, IL1B, LTA, BIRC2, TLR2, CXCR4, KCNA5, PTGS2, THBS1, ASCL2, CST3, PAK1, E2F1, PML, FABP1, TEK]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[CDA, NRP1, SEMA5B, CDKN1A, ARHGAP4, TCHP, PPP2R1A, HNF4A, TNR, SEMA6A, DCC, SIRT1, GREM1, PSRC1, SFRP2, NDUFS3, FBP1, RNF6, PAK1, FRZB, SPP1, APBB1, SEMA4A, TGFB2, TGFB1, CDKN2C, SEMA4B, INHBA, PML, BCL6, BCL2, SIPA1]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[NRP1, ADARB1, STMN1, EPHB2, EPHB1, DCC, PAX2, MAP1B, CDH11, DSCAML1, SLITRK6, APBB1, LINGO1, SEMA4A, GP5, POU4F1, PTK2, NR4A2, LRFN4, OGN, BCL2]
GO:0010811;positive regulation of cell-substrate adhesion;5.0;0.7980440201809971;0.6892630219514189;9.0094850440859;35.30989762708448;5.049685808968129;0.0011817904967337807;0.5484821789659555;[DOCK5, NRP1, CYR61, EMILIN2, CCR7, EMILIN1, CD36, PRKCE, EMP2, OLFM4, DNM2, CCDC80, MMRN1, CEACAM6, NINJ1, COL8A1, THY1, NID1, PRKCZ, EPB41L5, SPOCK2, FLNA, JUP, CCL21, FN1, CDK6, TEK]
GO:2000353;positive regulation of endothelial cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;6.943860283624253;0.00434501821119318;0.7513499630073597;[CD40, ITGA4, FASLG, THBS1, CD40LG, CCL2, PLCG1]
GO:0097527;necroptotic signaling pathway;5.0;1.0;0.7902410118609202;9.628524252492122;23.17027026302992;7.9853141584524145;7.75488093814194E-4;0.6986103492792611;[FASLG, TNF]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, JAK3, DUSP1, RIPK2, GMIP, SIRT1, DUSP6, PTAFR, NRAS, STAT4, DMD, STAT1, PKN1, LGR4, CTGF, SESN3, MAP3K8, KCNH1, KCNH2, CISH, CDC25C, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, G3BP2, TNFRSF10B, BMX, CORO2A, NFKB1, NFKB2, LRRK2, PIK3CD, FOXM1, TNFRSF1B, SPTB, LCP2, PIK3C3, LCP1, DTL, BIRC2, BIRC3, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, E2F8, IL2RA, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, TRIB1, RIN2, EPHA2, PIK3R5, RACGAP1, CD14, PAG1, CCR1, IGF1, PTK2, CALM3, RGL4, CD24, RGL1, CD40, CETN3, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR3, CCR2, IL18, GAB2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, RELB, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK2, DOK3, TYROBP, CARD11, CALCA, PSEN2, RASGRP1, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, GNAQ, PLEK, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, MASTL, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, AURKA, EPS8L1, EPS8L3, EGF, MAPK14, MAPK13, TEK, CYFIP1, EPS8, STMN1, CYP1B1, MED1, PRKCH, DAPK1, PRKCB, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, PRKDC, PRKCZ, PLCG2, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, BTG2, ADM, IFIH1, NFAM1, PAX2, CIT, HCLS1, PLCB1, HBEGF, EXOC1, GSN, CCL20, CARD9, POU4F1, CSF2, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, RAB31, CSF1R, DNMT1, CALCRL, CUL5, ITPR3, RASAL2, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK2, CDK1, BCL2, CSPG4, LAT, BCL2L1, PIK3C2A, TREM1, TLK1, GPX1, CHUK, TFDP1, IL3RA, CX3CR1, CEBPB, NLRC3, NOD2, RAB21, PLN, PML, DNAJA3, CALML4, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, STRADB, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, GUCY2C, SP100, PTGER2, CXCR5, CXCR4, CXCR6, AIF1, CXCR1, CXCR3, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, CSF2RA, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, GPSM2, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, CASP2, PTGIR, PDE4D, TGFBR3, ZAP70, DOCK2, CAMK2D, NCAM1, TSHR, PIKFYVE, RPS6KB1]
GO:0051402;neuron apoptotic process;5.0;0.8259837884571596;0.7032329060895001;9.022388448921806;23.44398779513952;6.113511981550823;7.846491732841165E-4;0.6028862989048107;[ADARB1, NAE1, CIT, BCL2, BCL2L1]
GO:0019800;peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan;9.0;1.0;0.896240625180289;9.628524252492122;433.4643727638907;7.9853141584524145;0.014507662463798891;0.8046099625986299;[SPOCK2, SPOCK3, BGN, DCN]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, CSF3, IFNA2, ARRB1, ARRB2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, RIPK2, MIF, SFRP2, IFNG, HCLS1, IFNA10, PTGS2, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, OSM, IL6, BCL2, CAMK1]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, ICAM1, HMOX1, GPX1, DAPK1, TNFRSF10B, SFRP2, BCL2L1]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[TNFAIP6, TNFAIP3, RORA, ETS1, CDH5, DUSP10, PBK, PGLYRP1, IL10, GHSR, GPX1, IL1R2, PRKCD, TNFRSF1B, ADCYAP1, CALCRL, NLRC3, GATA3, NT5E, NLRP3, ELANE, NR1H4, KLF4, NFKB1, NLRP12, IL2RA, TEK, FCGR2B]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[SERPINE1, TNF, ETS1, TNFSF11, FFAR2, CCR7, CCR2, TGM2, FCER1G, IL15, IL18, IL17RB, IL23A, IL1B, BTK, AGTR1, LTA, TLR10, TLR7, ADAM8, TLR6, TLR4, S100A9, S100A8, TLR2, SUCNR1, TNFRSF11A, NOD2, PTGS2, PLA2G7, C3, CNR1, CCL4, S100A12, CCL18, SNCA, IL33, CCL23, OSM, MAPK13, NFKBIA, NLRP12, IL6, CD6, CD28, MYD88, IL17A]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[GPX1, PRKCD, PML, MELK, BCL2, CYP1B1]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[CDKN1A, BCL2A1, PRKDC, BRCA1, BRCA2, TNF, PYCARD, E2F1, HMOX1, CASP2, SFN, MLH1, TNFRSF1B, SIRT1, PML, MSH6, MSH2, BCL3, BCL2, EPHA2, BCL2L1]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[ITGA2B, HMGB2, THBS1, GATA1, NFE2, MEF2C, GP1BA, NR4A3, PRKCQ, MYL9, PF4]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, ETS1, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, GPX1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, HDAC2, PCNA, KCNA5, FOXO1, CST3, PDGFD, HMOX1, ECT2, JUN, STAT1, KLF4, MAPK13, COL1A1, FABP1, FOSL1, IL6, NR4A3, FKBP1B, CDK1, BCL2, SDC1, EZH2]
GO:0009967;positive regulation of signal transduction;6.0;0.44130843764162375;0.5437745314109563;6.712834686611667;140.23187634019237;2.4492930892588385;0.004693434700611163;0.44837727507861835;[, SLA2, AKT1, WLS, ATF3, FPR1, PDGFA, FPR2, GATA3, SLC30A10, IQGAP3, C3, PDGFD, PDGFC, SFN, LYN, JUN, JAG1, JUP, EIF2AK2, COL1A1, NOX4, GPR18, NOX1, EZH2, SRPX, ARHGAP6, ARHGAP4, JPH2, GPR37, GPR35, RIPK2, EMP2, SIRT1, F3, DUSP6, MMP12, NTF3, FLNA, BIK, COL3A1, LRG1, PKN1, LGR4, NCF1, SLA, CTGF, RUVBL1, MAP3K8, ADCYAP1, MAL, S100A9, S100A8, LY96, TNFRSF11A, SOCS2, ZNF423, LY86, TNFRSF10B, NFKB1, CXCL10, CXCL11, PTPRC, HPSE, MYD88, LRRK2, ITGB3, PIK3CD, FASLG, ARRB1, ARRB2, HHEX, ADAMTS20, ACPP, BIRC2, BIRC3, CCL8, CCL7, CCL5, CCL4, E2F1, CCL2, CCL1, FYN, SH2B1, PRRX1, TIE1, GZMB, PTPN6, FCGR2B, ICAM1, LGALS1, DHX58, TNFSF11, TRIM25, EPHB2, EPHB1, RSAD2, ACTN4, MIF, EREG, BTC, SFRP4, SFRP2, EPHA3, NAIP, EPHA2, TGFA, PIK3R5, CD19, TSPAN5, CD14, PAG1, SLAMF1, CCR1, TNFSF14, TNFSF12, IGF1, PTK2, CD28, CD27, CALM3, CD24, NRP1, ECM1, CD40, SECTM1, CD3E, AKAP12, CTSH, CCR7, CD36, SYK, IL15, GAB1, IL18, BANK1, IL1B, KIT, YAP1, GNAI2, PAK1, CD74, OSM, PPP1CA, NLRP12, KITLG, NEDD4, IL18R1, CD86, CD80, IHH, IL6R, TGM2, PDGFRB, PDGFRA, CARD11, DDX60, RASGRP1, RASGRP4, ECT2, CAV2, CAV1, INHBA, GH1, IL6, BMP2, IL7R, TNFAIP3, GHR, NUP62, YWHAH, MYOCD, MMP9, GREM1, ELF3, IRF7, CHI3L1, SHANK3, EGF, MAPK14, CD4, TEK, CYFIP1, PHB2, EPS8, PROK2, CYP1B1, MED1, PRKCH, PRKCB, PRKCE, PRKCD, DEPDC1B, DAAM2, MAML3, SEH1L, PRKCZ, S100A12, HMOX1, ICOS, ELANE, NDFIP2, FZD5, PLK2, FZD8, TGFB1I1, TIMP2, TIMP3, HAVCR2, FCRL2, FCRL3, NFAM1, HCLS1, PLCB1, HBEGF, ENG, CCL13, GPNMB, CCL19, CCL18, CCL23, GSN, CCL21, CCL20, CARD9, NR1H4, G0S2, SULF1, SULF2, PF4, CSF3, CSF2, TNF, FGF5, PYCARD, CDH3, GRAP2, MEN1, MAP2K2, IGFBP5, IGFBP3, CD180, F2R, ADAM9, ADAM8, CSF1R, NACC2, PSAP, CD300LF, DRD4, MAP2K6, DAB2, CDK1, BCL2, CSPG4, CCDC22, LAT, BCL2L1, PLEKHF1, TREM2, PTPN22, CYR61, GPX1, CHUK, ASPM, TFDP1, LCK, XCL2, XCL1, NLGN1, HDAC2, TTK, NOD2, CSK, PML, P2RX5, IL1RN, GFI1, PPP2R1A, SKP2, SOX4, IL1R1, POR, IL23A, RRAGD, SH2D2A, TXK, TP53BP2, GADD45B, SH2D1A, LIF, MARCO, ITM2C, IFNA2, PRL, ESM1, MAP4K1, EDN1, PARP9, ZDHHC17, VAV1, TLR1, MDFIC, TLR7, TLR6, TLR5, TLR4, TLR2, CXCR4, CTNNA1, SORBS1, CD40LG, F2RL1, F2RL3, GOLT1B, GHSR, C5AR1, ADRB2, STAP1, TGFB2, TGFB1, SELP, LIN28A, CXCL9, BLNK, CASP2, PLAUR, ARAP1, AXIN2, DCN, TGFBR3, FGR, ZAP70, IFNG, PDE5A, LTF, DLL1, THBS1, TRAT1, LTBR]
GO:0046627;negative regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;294.34753946768484;6.311337724880743;0.009851547250396369;0.6736814700148209;[PID1, CISH, PRKCB, PRKCD, TSC2, SLA2, PRKCZ, SOCS2, PTPRE, RPS6KB1, IL1B, PRKCQ]
GO:0042149;cellular response to glucose starvation;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;115.90251486529202;6.063501560976162;0.003879152867050031;0.6610071170671804;[SESN3, UPP1, BCL2, SIK1, PIK3C3]
GO:0007416;synapse assembly;4.0;0.8436909121759173;0.6718454560879586;9.117698628726131;35.85243951974866;5.500407508664414;0.0011999488856252476;0.5312910957882058;[ACHE, NLGN1, FZD5, PLXND1, PCDHB15, PCDHB14, PCDHB10, POU4F1, CDH1, SPOCK2, PCDHB16, SLITRK6, PCDHB4, SHANK3, PCDHB8, SDK2]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[CDA, CYFIP1, CPNE5, KIAA1109, PPP2R1A, DPYSL2, RPS6KA1, AKT1, SFRP2, MAP1B, AGTR1, PRKCQ, NEDD4L, EPB41L3, SFN, FN1, IGF1, FXYD2, NRP1, CDKN1A, KIF14, ARHGAP4, ESM1, HNF4A, CD38, EDN1, AVPR1A, SIRT1, IL17RB, CEACAM1, SGK1, HBEGF, PAK1, FRZB, SPP1, APBB1, CDKN2C, KIF26A, SIPA1, SEMA5B, CTGF, CXCL16, TNR, SEMA6A, IGFBP5, CISH, IGFBP3, S100A9, S100A8, HTRA1, SOCS2, IGFBP7, TGFB2, TGFB1, SYT2, CRIM1, INHBA, CXCL12, BCL6, BCL2, CYR61, TCHP, MYOCD, DCC, DNM2, GREM1, PSRC1, NDUFS3, FBP1, CAMK2D, TAF9, LEF1, RNF6, RAB21, SEMA4A, SEMA4B, PML]
GO:0001836;release of cytochrome c from mitochondria;6.0;1.0;0.8231203125901445;9.628524252492122;22.134985108306864;6.686031174322154;7.408380313817617E-4;0.665044257777226;[JUN, BCL2A1, IFI6, BCL2, SFN, SOD2, CLU, BCL2L1]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, TNFSF13B, CD38, NCKAP1L, CD74, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, BCL2, CARD11, CD320]
GO:0031069;hair follicle morphogenesis;4.0;1.0;0.75;9.628524252492122;21.56700107071243;6.518977089658987;7.21828116795923E-4;0.5833807915285978;[TGFB2, IGFBP5, BCL2]
GO:0031103;axon regeneration;7.0;0.8436909121759173;0.7727648213451592;9.427853557029971;96.50678923292918;6.832634648514029;0.00322999538515464;0.7003406189322132;[DHFR, JUN, CHL1, TNC, CTNNA1, BCL2, JAM3]
GO:0035265;organ growth;3.0;0.7671156992804218;0.5816781622303554;8.753055515138222;22.582921643529833;6.444869117505266;7.558300640989654E-4;0.5277112189764278;[PDGFRB, PSAP, BCL2, DLL1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[IFITM1, SPARC, LST1, SPINT2, ADARB1, PHB2, IFIT3, CYP1B1, EPHB1, SOX7, SOX4, MED1, MEF2C, HLA-G, EREG, SFRP4, SFRP2, SPINT1, BTK, TRIB1, GATA3, GATA1, BRIP1, INPP5D, HMOX1, SFN, S100A11, LYN, JUN, BCL11B, FZD5, LIF, EIF2AK2, CDC6, NR2F2, FOSL1, NOX4, SNAI2, SRPX, CDKN1A, BTG2, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, HNF4A, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, IL15, PAWR, PDCD1LG2, CBFA2T3, NME1, IL1A, CEACAM1, ZEB1, IL1B, RARA, TLR2, PTGS2, ASCL2, AIF1, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, STAT1, OSM, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CDKN3, CD86, CD80, SIRPG, IHH, TNF, ETS1, CDH5, DACH1, MEN1, IGFBP5, CD300A, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, MAD1L1, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, CDK6, BCL6, OGN, BCL2, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, KLF13, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPA, CEBPB, NLRC3, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, SOD2, PML, MEIS1, DNAJA3, IL2RA, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0014042;positive regulation of neuron maturation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;592.6446807852996;8.390779266560578;0.019835284120298998;0.8253454670833372;[BCL2]
GO:1904355;positive regulation of telomere capping;9.0;0.9326813400603323;0.8625812952104552;9.59462270081644;613.4505056642549;6.943860283624253;0.02053163635497091;0.7513499630073597;[NEK7, PRKCQ, NEK2, AURKB]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, PRKCH, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PRKDC, PDGFA, IQGAP3, GATA1, PRKCZ, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, MCTS1, JUN, FN1, CDC7, CDC6, FOSL2, FOSL1, NOX1, CDKN1A, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, RIPK2, FCRL3, EMP2, SIRT1, F3, PAX2, MMP12, RARA, HCLS1, HBEGF, PTAFR, KCNA5, PTGS2, NRAS, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, STAT1, LRG1, HLA-DPB1, CSF3, CHRM1, CSF2, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, PPP1R16B, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, DNMT1, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, CDK6, BCL6, CDK2, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, ARRB1, FOXM1, CYR61, TNFSF13B, LBH, ITGA4, ASPM, XCL1, BIRC5, CX3CR1, HDAC2, SMARCD3, TTK, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, IL2RA, PTPN6, CCNF, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, TIPIN, FLT3LG, MIF, RUNX2, EREG, HLA-E, BTC, SFRP2, IL23A, KIF20B, EBI3, TGFA, TWIST1, CD1D, PKHD1, SLAMF1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, IGF1, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, KIF14, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR3, CCR2, IL10, EDN1, SYK, IL15, RHOG, IL18, PDCD1LG2, AVPR1A, GAB2, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, AIF1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, OSM, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, ETS1, IL6R, TGM2, PDGFRB, GHSR, PDGFRA, MATK, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, TBC1D8, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, LEF1, DLL1, THBS1, HLX, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, RPS6KB1, TEK]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, GAB2, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG2, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, TGM2, PRKCB, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, SECTM1, FASLG, NUP62, CCR7, CD36, CHUK, RIPK2, ZDHHC17, IL1B, TLR6, BIRC2, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, F2RL1, LTBR]
GO:0097192;extrinsic apoptotic signaling pathway in absence of ligand;7.0;1.0;0.8509193652572005;9.628524252492122;76.30875120206336;6.375876246018314;0.0025539852293156346;0.6769819729871445;[BCL2A1, DCC, IL1A, IL1B, BCL2, CASP2, BCL2L1]
GO:1904996;positive regulation of leukocyte adhesion to vascular endothelial cell;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;71.15170694072506;7.8311634786251565;0.002381383598927155;0.7514054297404357;[ITGA4, PTAFR, TNF, ETS1, ELANE, CCR2, ICAM1]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, PRKDC, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, FOSL2, FOSL1, HOXC10, DLGAP5, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, ZEB1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, STAT1, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, SBNO2, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, FOXM1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, IGF1, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, APBB1, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL2, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0040018;positive regulation of multicellular organism growth;6.0;1.0;0.8231203125901445;9.628524252492122;145.45792876686207;6.280566066213989;0.004868345972189967;0.6443087532925187;[GHSR, GHR, VIL1, GH1, BCL2, PLS1]
GO:0043525;positive regulation of neuron apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.392135474427892;179.36331192335928;5.885253329569843;0.0060031286335741505;0.6759721289664703;[CTSZ, FASLG, MYB, CASP2, MYBL2, JUN, TGFB2, CDC34, IL1B, UBE2M]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, BTG2, KIF14, ARRB1, ARRB2, CHL1, MEF2C, F2R, MSH2, ADAM8, NAIP, CEBPB, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, SOD2, POU4F1, NR4A2, NR4A3, BCL2, BCL2L1]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[SLC46A2, PRKDC, GATA3, CCNB2, HOXA3, BCL11B, MAFB, BCL2, MAD1L1]
GO:2000811;negative regulation of anoikis;8.0;1.0;0.875;9.628524252492122;103.9210822679579;6.943860283624253;0.0034781451006065307;0.7301093378270707;[CAV1, PTK2, CEACAM6, CEACAM5, BCL2, SNAI2]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, RIPK2, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, ZEB1, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, STAT1, IL10RA, HLA-DPB1, PF4, CSF3, CSF3R, CSF2, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, MAP3K8, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, CD300LF, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC2, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RA, IL2RB, PTPN6, IL1RN, IFITM1, IFI30, IFIT1, IFIT3, IFIT2, ICAM1, TNFSF11, TRIM25, IL15RA, RSAD2, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IFI27, IL23A, EBI3, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, IL10, SYK, IL15, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, LMNB1, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, IRF8, LTB, CAMK2D, SAMHD1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0048388;endosomal lumen acidification;12.0;1.0;0.9481203125901445;9.628524252492122;182.53781204849716;8.67846133901236;0.006109376295897887;0.8919372290569614;[FASLG]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ICAM1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, TYMS, AIF1, FOXO1, IGFBP7, TGFB1, FOSL1, IL6, RPS6KB1, BCL2, ALPL, SDC1, FOSB]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[CDKN1A, BTG2, CASP2, SOX4, CDC25C, TFDP1, PCNA, PRKDC, AURKA, CCNB1, GPNMB, NACC2, E2F1, CCL2, SFN, E2F7, E2F8, PLK2, RPA2, KLF4, PML, CNOT3, CDK2, CDK1, BCL2, EZH2]
GO:2000810;regulation of bicellular tight junction assembly;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;28.92769022108224;6.781341354126479;9.681837584686441E-4;0.6699184248047958;[PRKCH, FZD5, GPBAR1, SNAI2, TNF]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, PIK3CD, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, RIPK2, PDE4D, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, TXK, GATA3, THY1, PAK1, INPP5D, PLCG2, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, BTNL8, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, NFKBID, LAT, HLA-DRB1]
GO:0030644;cellular chloride ion homeostasis;9.0;1.0;0.896240625180289;9.628524252492122;141.59530137466902;8.390779266560578;0.004739067309512229;0.8253454670833372;[FASLG]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, TXK, PIK3CD, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, PLCG2, CTLA4, CD38, NCKAP1L, IGHA1, LYN, MEF2C, SYK, PRKCB, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, BCL2, PTPN6, MNDA]
GO:2000378;negative regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;113.12708673636307;5.905872616772578;0.003786261785297929;0.6251469128630576;[HP, BRCA1, SLC30A10, CD34, IL10, CAV1, PAX2, BCL2]
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;570.2036429558796;6.221725566191056;0.019084202779771145;0.7334203466557586;[CX3CR1, CSF2, STRADB, IFI6, TNF, GATA1, IL1A, IL1B, CTNNA1, BCL2, AKT1, SNAI2, FYN, PF4, BCL2L1]
GO:0033077;T cell differentiation in thymus;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;66.99450330244977;6.481236761676141;0.002242245734394454;0.6823701146576509;[BCL11B, FZD5, PRKDC, FZD8, MAFB, DNAJA3, BCL2, CCR6]
GO:0000209;protein polyubiquitination;10.0;0.7671156992804218;0.7987988615011312;9.223059144383958;155.4032479663248;4.243684138952949;0.005201206855589802;0.6322632160784685;[CCNF, HERC5, SKP2, FBXW2, CDC34, NEDD4L, BARD1, HACE1, UBE2C, MARCH1, UBE2S, UBE2T, BCL2, TNFAIP3, BRCA1, UBE2Q2, RNF144A, RNF144B, DTL, BIRC2, RNF6, ZNRF1, RNF24, NEDD4]
GO:0060252;positive regulation of glial cell proliferation;9.0;0.8933024483968273;0.8428918493787028;9.587702257971866;465.4406966640378;7.292166977892469;0.015577881247913653;0.769162383550154;[LYN, PRKCH, MYB, LTA]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, TXK, SLA, SLA2, GRAP2, FYN, CSK, JAK3, LYN, SYK, MATK, BMX, PTK2, FGR, ZAP70, HCK, LCK, FES, BTK]
GO:0043375;CD8-positive, alpha-beta T cell lineage commitment;6.0;1.0;0.8231203125901445;9.628524252492122;44.46807846579176;9.777073627680469;0.0014883065675776633;0.8231203125901445;[BCL2]
GO:0035094;response to nicotine;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.17342148764107;5.926926025970411;8.760008626412986E-4;0.5531032725983739;[CHRNB4, EDN1, HDAC2, VCAM1, SLC7A11, TNF, NFKB1, CNR1, BCL2, HMOX1]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[LYN, MEF2C, TNFRSF13B, TNFAIP3, TNFSF13B, BCL2, NCKAP1L, PKN1]
GO:0043536;positive regulation of blood vessel endothelial cell migration;10.0;0.9326813400603323;0.8815816818910864;9.584072489921288;355.43002650478036;5.8067817141283475;0.011895923120858621;0.7122000987644093;[NRP1, CD40, PTGS2, PIK3C2A, THBS1, ETS1, AKT1, HMOX1, PLCG1, TGFB1, ANXA1, PLK2, SIRT1]
GO:0045954;positive regulation of natural killer cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.526741558182179;431.31665099041965;6.444869117505266;0.014435780148864921;0.7258315315665724;[LAG3, SH2D1A, CRTAM, RASGRP1, VAV1, IL18RAP, KLRK1]
GO:0001541;ovarian follicle development;4.0;1.0;0.75;9.628524252492122;34.608406302298;6.166155715036245;0.001158312213394382;0.5653374900225189;[CEBPB, INHBA, FANCG, ICAM1, ADCYAP1, KIT, CTNNA1, BCL2, MMP19, BCL2L1]
GO:0001662;behavioral fear response;5.0;1.0;0.7902410118609202;9.628524252492122;37.889479621082295;6.375876246018314;0.0012681267845998157;0.6163036195908642;[GABRA5, DPP4, ADCYAP1, RPS6KB1, BCL2, DRD4]
GO:0050861;positive regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;365.0896954818653;7.8311634786251565;0.01221922354838398;0.7754860644832351;[LYN, PRKCH, PRKCB, NFAM1, STAP1]
GO:1990830;cellular response to leukemia inhibitory factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[TFRC, ICAM1, TNFSF11, TRIM25, MYBL2, TLE4, PCOLCE, SIRT1, PADI2, SBNO2, SPOCK2, LAPTM5, KLF4, PML, BSPRY, KLF5]
GO:0001658;branching involved in ureteric bud morphogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;53.5045405888233;6.015873511986907;0.0017907488225476112;0.6585714164269392;[PAX2, HOXA11, GREM1, BMP2, BCL2]
GO:0010523;negative regulation of calcium ion transport into cytosol;9.0;0.8259837884571596;0.8092325194088689;9.417215158824915;155.07739949607335;6.943860283624253;0.00519030100053507;0.7513499630073597;[TGFB1, FKBP1B, BCL2, CALM3]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, ICAM1, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, SIRPA, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, DOK2, PRTN3, ADAM8, S100A9, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, FUT7, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, ESAM, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, PIK3CD, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, PDE4D, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, SLC7A9, IL1B, CEACAM5, KIT, PECAM1, XCL2, XCL1, CD48, CEACAM8, CX3CR1, CCL13, SELPLG, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR3, TBX21, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, F2RL1, PTPN6, TEK, CD244, PF4]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, CSF3, SPARC, CSF2, CD80, GFI1, SERPINE1, CXCL13, MPO, LOXL1, ICAM1, PYCARD, EDNRB, JUNB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, TRIB1, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, SBNO2, KLRK1, PLCG2, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, NFKB2, SELP, CXCL10, CXCL11, IL6, ALPL, CD27, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, ADM, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, PDE4D, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, RARA, IRF8, TLR4, CX3CR1, CEBPB, HDAC2, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, IL10RA, NR1H4, LILRB1, LILRB2, MAPK14, CD6, RPS6KB1, TNIP3, LTBR, PF4]
GO:0070059;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.12593595584649;6.343086423195323;0.002815619368015229;0.6753050999230941;[PPP1R15A, CEBPB, TNFRSF10B, PML, BCL2]
GO:2000147;positive regulation of cell motility;6.0;0.5781283279524737;0.6121844765663813;8.052987891733702;115.84051076538883;3.630744370011572;0.0038770776456263385;0.5087967485194164;[SPARC, SERPINE1, MYLK, ICAM1, LGALS3, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, CLDN7, PFN1, KIF20B, TWIST1, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, IGF1, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, TACR3, SIRT1, F3, IL1A, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, AIF1, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, F2RL1, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, ETS1, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, ADAM8, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, VIL1, CXCL10, CXCL11, IL6, BMP2, DAB2, CXCL12, PTPRC, NR4A3, BCL2, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, PIK3CD, LAMC2, CXCL1, CXCL3, PIK3C2A, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL2, XCL1, LEF1, THBS1, P2RY6, CCL8, CCL7, CCL5, SPOCK2, CCL4, CCL1, SEMA4A, EGF, SEMA4B, LAMB1, MAPK14, SOD2, RPS6KB1, TEK]
GO:0070528;protein kinase C signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;7.212124270218933;8.845336528452411E-4;0.6919486831672181;[PRKCH, PLEK, AZU1, PRKCZ]
GO:0002320;lymphoid progenitor cell differentiation;5.0;0.8653626801206646;0.7229223519212526;9.223059144383958;22.164838071467113;7.379178354882098;7.418371831928127E-4;0.6676125360964777;[SPI1, PRKDC, KIT, BCL2, GATA3, SOX4]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[TGFB1, SLC46A2, TNFSF14, RIPK2, CACNA1F, CORO1A, CCNB2, SIT1, BCL2, NCKAP1L, JAK3]
GO:0060326;cell chemotaxis;5.0;0.6393367784920305;0.6099094011069355;8.152617732682543;30.286927728949156;4.458953633836253;0.0010136762146226118;0.5182721080578558;[IL1RN, CSF3R, CXCL13, CXCL16, LGALS3, EDNRB, CCRL2, C3AR1, TNFSF11, IL6R, EPHB1, PDGFRB, PDGFRA, CXADR, PRKCD, CH25H, HOXB9, BIN2, AGTR1, PRKCQ, ADAM8, S100A9, S100A8, EPHA2, CALCA, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, CORO1A, NUP85, S100A12, NCKAP1L, CCR10, CCR1, TGFB2, EGR3, VCAM1, AZU1, DEFA1, PPBP, NR4A1, CXCL10, CXCL11, IL6, CXCL12, NRP1, CXCL6, CXCL9, DOCK4, ITGB2, HMGB2, PIK3CD, CXCL1, ARRB2, CXCL3, CXCL2, CXCL5, CCR9, PDE4B, FFAR2, CCR7, CCR6, CCR5, CCR3, CCR2, IL10, ANXA1, FCER1G, SYK, PDE4D, RHOG, GAB1, VAV1, IL1B, KIT, XCL2, XCL1, HBEGF, CX3CR1, CCL13, LEF1, CXCR5, CXCR4, CXCR6, CCL8, CXCR1, CCL7, CCL5, CXCR3, CXCR2, CCL4, CCL2, CCL1, CCL19, CCL18, CCL23, CCL21, CCL20, PF4]
GO:2000318;positive regulation of T-helper 17 type immune response;8.0;0.8933024483968273;0.8216512241984136;9.56398573135455;171.5773823021682;7.474488534686424;0.005742540576034618;0.7572456912631272;[IL23A, NLRP3, PRKCQ, IL12RB1, NFKBID]
GO:0050870;positive regulation of T cell activation;8.0;0.6260725219892441;0.688036260994622;8.781226392104918;216.0655637178415;4.493869898942481;0.007231519971253338;0.6048167156182404;[CD86, CD83, TFRC, CD80, SIRPG, IHH, PYCARD, LGALS1, GRAP2, MYB, AKT1, TNFSF11, SIRPA, MAP3K8, IL6R, ICOSLG, HLA-G, HLA-E, IL23A, PRKCQ, ADAM8, CARD11, CD274, BLM, HHLA2, EBI3, GATA3, CD1D, THY1, CORO1A, PRKCZ, RASGRP1, DPP4, KLRK1, BTLA, NLRP3, NCKAP1L, ICOS, LYN, TGFB1, EGR3, VCAM1, TNFSF14, CAV1, IGF1, IL6, VNN1, PTPRC, BCL6, CD28, CD27, CD24, IL7R, NFKBID, CD3E, SIRPB1, TNFSF13B, DUSP10, CTLA4, CCR7, JAK3, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, RIPK2, IL15, IL18, PDCD1LG2, VAV1, ZAP70, IFNG, LCK, IL1B, RARA, XCL1, NOD2, AIF1, HSPD1, PAK1, HLA-DMB, HLX, CCL5, CCL2, FYN, CSK, CCL19, IL12RB1, CD74, CCL21, LILRB1, LILRB2, LILRB4, CD4, CD40LG, CD6, CD5, DNAJA3, IL2RA, HLA-DPB1, PTPN6]
GO:0001865;NK T cell differentiation;8.0;1.0;0.875;9.628524252492122;92.19446145895849;8.67846133901236;0.0030856656554028718;0.8188169164668168;[ITK, BMX]
GO:0002317;plasma cell differentiation;9.0;1.0;0.896240625180289;9.628524252492122;149.8071031872776;8.67846133901236;0.005013908926038414;0.8400575416471059;[LGALS1, ITM2A, NKX2-3]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFITM1, PRF1, ADARB1, IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, PTPRC, BCL2, SERINC5, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, ZMYND11, EXOC1, UNC93B1, SAMHD1, IL33, STAT1, MX2, CARD9, LILRB1, PML, F2RL1]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H2, SUV39H1, MPL, RORA, PHB2, SLC8A1, AQP1, ICAM1, AKT1, EDN1, KCND2, PRKCE, SIRT1, CCNA2, ADAM8, TWIST1, PTGS2, CCNB1, BRIP1, E2F1, HMOX1, FABP1, BCL2]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[FASLG, TNF, PYCARD, CTSH, F2R, F3, IFI27, LCK, S100A9, S100A8, NLRC4, HSPD1, NLRP3, SNCA, CASP8AP2, TNFRSF10B, HSPE1, PML, NLRP12, P2RX1, DLC1]
GO:0048041;focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;92.53238439646684;6.599019797332524;0.0030969756320103773;0.712474179321389;[ACTN1, PTPRK, SORBS1, THY1, ARHGAP6, DLC1, BCL2]
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway;9.0;0.7436939687323844;0.7680876095464813;9.413412872875176;597.3701724921605;5.233778845410465;0.0199934420750612;0.663896318730187;[LRRK2, CLU, AKT1, GPX1, PLAUR, MIF, MMP9, SIRT1, SFRP2, NDUFS3, BCL2A1, TAF9, PTGS2, FIGNL1, CD74, WFS1, SOD2, VNN1, CXCL12, BCL2, SNAI2, GRINA, BCL2L1]
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway;9.0;0.7671156992804218;0.7797984748205;9.413412872875176;596.4251749563025;5.75172193694532;0.019961813857978603;0.6903839525180965;[PLEKHF1, NACC2, CAV1, SIRT1, LCK, BCL2, S100A9, ATF3, S100A8, NOX1, BCL2L1]
GO:0045618;positive regulation of keratinocyte differentiation;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;360.6004015365146;7.069023426578259;0.012068970920135338;0.7365101867784198;[MED1, PRKCH, VDR]
GO:2000570;positive regulation of T-helper 2 cell activation;11.0;1.0;0.9324289523296623;9.628524252492122;326.26765218285163;9.777073627680469;0.010919884696736623;0.9324289523296623;[PRKCQ]
GO:0060271;cilium assembly;6.0;0.8653626801206646;0.7558016526504768;9.405380701177911;137.68250629835126;4.347727998726029;0.00460810957959482;0.5454633246350222;[PKHD1, EHD3, ABLIM1, ABLIM3, POC1A, FLNA, GSN]
GO:0014031;mesenchymal cell development;4.0;0.8653626801206646;0.6826813400603323;9.474373572664863;32.15320660831846;6.409777797693995;0.001076138889173156;0.5777963346592216;[EDN1, JAG1, EDNRA, BCL2, SNAI2]
GO:1900740;positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;990.0589542238915;6.599019797332524;0.033136382202663156;0.7527151911823093;[GZMB, TFDP1, TP53BP2, E2F1, BCL2, SFN, YWHAH]
GO:0046666;retinal cell programmed cell death;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;29.711636272016438;9.083926447120524;9.944217272877711E-4;0.7547934328124444;[FASLG]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IL10, IFNA4, IFNA7, MEF2C, CR2, CD40, IFNA14, IFNA16, IFNA2, CD180, PRKCD, LEF1, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, BCL2, IL7R, MS4A1, CARD11, IFNA21, IFNA10]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, JAK3, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, RIPK2, IL15, IL18, PDCD1LG2, HLA-E, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, EBI3, CD1D, CORO1A, AIF1, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, IGF1, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, IL2RA, CD28, HLA-DPB1, CD24]
GO:0042985;negative regulation of amyloid precursor protein biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;967.9208223894049;7.9853141584524145;0.032395438853188026;0.8046099625986299;[ITM2A, ITM2C]
GO:0051973;positive regulation of telomerase activity;9.0;0.9326813400603323;0.8625812952104552;9.600353375525426;952.4250073221435;6.193554689224359;0.031876807868214944;0.7129793000169707;[AURKB, NEK2, CCT4, CCT2, NEK7, KLF4, GRHL2, GREM1, PRKCQ]
GO:0070233;negative regulation of T cell apoptotic process;10.0;0.8259837884571596;0.8282329060895002;9.370695143190021;155.57980234840144;6.7325511899570465;0.005207115971869279;0.7595439928109722;[BLM, SLC46A2, CCL5, CD27, PRKCQ, IL7R, JAK3]
GO:0010507;negative regulation of autophagy;7.0;0.7436939687323844;0.7227663496233927;9.117698628726131;217.48068666745357;5.500407508664414;0.007278882862848883;0.6322104610454062;[LRRK2, PTPN22, AKT1, TSC2, HMOX1, SNCA, PTK2, BCL2]
GO:0046671;negative regulation of retinal cell programmed cell death;7.0;0.9326813400603323;0.8172600352873667;9.584072489921288;304.76275982415854;9.777073627680469;0.010200135302637775;0.8509193652572005;[BCL2]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, ETS1, CTGF, RUVBL2, CD38, PDGFRB, IL10, GHSR, POSTN, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, CST3, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0010744;positive regulation of macrophage derived foam cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;113.85781812010546;7.004484905440688;0.0038107187070962377;0.6813299963962409;[MSR1, PRKCH, CSF2, AGTR1, IL18, CD36, NFKB1, PF4]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, CSF3, CSF2, NCF1, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, FAM3D, EPHB2, PHLDA2, MED1, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, NBL1, IFNA10, CALCA, EBI3, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, IGF1, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, FBN1, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, SECTM1, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, TNFSF12-TNFSF13, IL10, EDN1, IL15, PDE4D, IL18, GREM1, IL1A, IFNG, IL1B, LTA, XCL2, XCL1, LTB, SHANK3, HBEGF, CCL13, NLGN1, GRN, CLEC12B, RETN, TYMP, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, SPP1, CCL2, CCL1, CCL19, CCL18, IL32, CMTM8, IL33, CCL23, CCL21, EGF, CCL20, OSM, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCH, PRKCB, PRKCE, PRKCD, VRK1, PRKCQ, PRKDC, PRKCZ, CCNB1, CLSPN, PLK2, PLK1, CDC7, CLK1, CDK2, CDK1, BCL2, LRRK2, MAP4K1, CHUK, SYK, MASTL, SGK1, CAMK2D, TTK, AURKB, AURKA, MAPK14, MAPK13, RPS6KB1, CAMK4, PKN1, CAMK1]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[SIRPG, TNF, SIRPB1, C2, PYCARD, C3, STAP1, CCL2, SIRPA, NCKAP1L, CD36, CD300LF, FCER1G, SLC11A1, AZU1, DNM2, IL1B, F2RL1, PTX3, FCGR2B, DOCK2]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[LRRK2, CHEK1, AKT1, PRKCB, PRKCD, CAD, VRK1, CAMK2D, TTK, CLK1, CDK1, BCL2, PKN1, CAMK1]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[IL1RN, IFITM1, SERPINE1, ADARB1, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, IGFBP5, CD300A, IGFBP3, TPM1, MIF, SFRP2, PADI2, TRIB1, NBL1, VCL, TACSTD2, THY1, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, BCL2, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, GREM1, TMEFF2, PLCB1, ENG, CX3CR1, SP100, LRP1, THBS1, AIF1, CCL2, IL33, CCL21, TIE1, PODN, KLF4, SULF1, COL3A1, DLC1]
GO:0033689;negative regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.18040277096193;7.57984905034425;0.0021145912220731796;0.710754145523778;[GREM1, BCL2, EIF2AK2]
GO:0032753;positive regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;6.686031174322154;0.0021737836760178982;0.665044257777226;[CD86, IL33, CEBPB, PRG2, GATA3, CD3E, PRKCZ, HLA-E, CD40LG, CD28, RARA, NLRP3, PRKCQ, HAVCR2]
GO:0030578;PML body organization;6.0;1.0;0.8231203125901445;9.628524252492122;22.525182744284425;8.390779266560578;7.538975951028572E-4;0.7522251544931926;[ETS1, PML]
GO:0006582;melanin metabolic process;5.0;0.811012628672052;0.6957473261969462;9.318369324188282;72.72537912965618;7.212124270218933;0.002434052990877658;0.659069382437994;[TRPC1, BCL2]
GO:0045742;positive regulation of epidermal growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;233.1839134473908;6.280566066213989;0.0078044557311868065;0.6961884407023742;[NCF1, EGF, PLAUR, TGFA, FASLG, ARAP1, MMP9, EREG, NUP62, AKT1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, PKIA, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, ZEB1, TAL1, RARA, HCLS1, ASCL2, STAT1, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CDK2, CIITA, FHL2, FASLG, FOXM1, HHEX, RFC1, PEG3, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H2, SUV39H1, BMI1, XPO1, CD36, HBZ, EDN1, PARP9, IL1B, SP100, SATB2, RELB, RXRA, APBB1, CDX2, LILRB4, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TIMELESS, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, IRF8, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0045595;regulation of cell differentiation;4.0;0.3376379861120121;0.41881899305600606;5.249000748036359;23.33457331431992;2.3564947222696686;7.809871690777242E-4;0.3705112496850823;[SPI1, KIAA1109, DPYSL2, AKT1, PGLYRP1, MEF2A, MEF2C, SPINT1, AGTR1, MYL9, GATA3, THY1, ADAMTS12, GATA1, EPB41L5, SFN, LYN, ABCA1, JUN, JAG1, FN1, EIF2AK2, COL1A1, EZH2, ARHGAP4, CTLA4, JAK3, RIPK2, EMP2, FOS, SIRT1, DUSP6, PTGS2, FRZB, NTF3, CLPTM1, SPP1, FLNA, IL12RB1, STAT1, TMEM64, COL3A1, RORA, CTGF, EFEMP1, HLA-DOA, ATP11C, OLFM4, ADCYAP1, S100A9, TACSTD2, FOXO1, SOCS2, GPR98, NFKB1, CXCL10, CXCL12, LRRK2, ITGB3, ARRB2, ADAMTS20, BIRC2, LRP1, LRP2, E2F1, FYN, CTHRC1, LINGO1, PRRX1, USH2A, IL2RA, PTPN6, FCGR2B, CPNE5, CDC20, LGALS3, LGALS1, TNFSF11, EPHB2, EPHB1, PAQR3, HNF1B, ACTN4, EREG, BTC, SFRP4, SFRP2, BTK, TRIB1, KIF20B, EPHA3, SDC2, CCR1, MSR1, EGR3, TNFSF14, IGF1, PTK2, ID1, CD28, CD27, CD24, NRP1, CTSZ, KIF14, CD38, CD36, CD34, CCR2, CD53, SYK, IL15, IL18, RGMA, IL1B, KIT, YAP1, PAK1, CD74, SORT1, TMEM176B, TMEM176A, XK, NEDD4, FKBP1B, IL17A, FOXA2, SCARB2, CD86, CD83, CD80, MPL, IHH, ETS1, LOXL2, IL6R, EOMES, PDGFRA, TYROBP, CARD11, RASGRP1, ECT2, SYT2, VDR, CAV1, ISG15, INHBA, IL6, BMP2, COL5A1, GNAQ, COL5A2, TCF4, IL7R, FBN1, HMGB2, CA2, YWHAH, MYOCD, GREM1, IRF7, SHANK3, RNF6, AURKA, CNR1, TBX21, SPOCK2, RBM38, MAPK14, SOD2, CD2, CD4, ACIN1, CYFIP1, SERPINE1, HOXA9, MYB, GPR171, HOXA2, HOXA7, JUNB, HOXA5, MED1, PRKCH, PRKCB, DAAM2, MAP1B, LGALS12, HOXB4, HOXB3, PRKCQ, NEDD4L, PRKCZ, FLRT2, PRDM16, NCKAP1L, FZD1, NFE2, PLK2, SNAI2, TGFB1I1, ADM, TIMP2, ANXA1, FCRL3, NFAM1, PAX2, ZEB1, TAL1, RARA, HCLS1, PLCB1, ENG, ASCL2, CCL19, NR1H2, POU4F1, PF4, SEMA5B, CSF3, CSF3R, CSF2, PLXND1, FMR1, ITGA2B, TNF, CDH5, TNR, MEN1, LHCGR, SEMA6A, IGFBP5, IGFBP3, ADAM8, DNMT1, HOPX, DAB2, MAFB, CDK6, BCL6, SYNJ1, MAFF, CDK1, BCL2, PLXNB2, CYR61, LBH, DUSP10, CR1, ASPM, ASPA, CX3CR1, CEBPA, NLGN1, CEBPB, HDAC2, SMARCD3, RAB21, SEMA4A, SEMA4B, IRX3, KLF4, KLF5, EVI2B, IFITM1, SLC46A2, GFI1, EDNRB, PPP2R1A, RPS6KA1, FLT3LG, HLA-G, RUNX2, POR, IL23A, SIK1, NBL1, TWIST1, INPP5D, BCL11B, LIF, VNN1, ITM2C, ROBO2, IFNA2, EDN1, GP1BA, NME1, CEACAM1, CEACAM5, FAM20C, TLR4, TLR2, CXCR4, PDPN, CTNNA1, APBB1, CDX2, LILRB1, LILRB2, LILRB3, GRHL2, LILRB4, CAMK4, CAMK1, C1QC, HOXA11, ARHGDIA, POSTN, LMO2, FANCD2, FBLN1, LTBP3, STAP1, NLRP3, TGFB2, TGFB1, NFKBIA, LIN28A, NR4A3, FES, NFKBID, DOCK5, CXCL9, TMEM100, KLF13, DCC, AXIN2, DNM2, ZAP70, IFNG, LTA, PDE5A, LTF, HEMGN, LEF1, DLL1, THBS1, HLX, S1PR3, S1PR5, MEIS2, MEIS1, PMP22]
GO:0010559;regulation of glycoprotein biosynthetic process;7.0;0.6634067003016617;0.6826227154080313;8.902587249109185;149.75732045160512;6.139487467954083;0.00501224274267701;0.6648930398837374;[CCL21, IL15, PAWR, IGF1, GATA1, BCL2, CCR7, CCL19, PLCB1, ITM2A, RAMP1, JAK3, HBEGF, ITM2C]
GO:0032740;positive regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[TGFB1, IL23A, IL15, IL18, PRKCQ, NOD2, LY9, MYD88]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[PROS1, SERPINE1, SPINT2, AQP1, PTTG1, LAMP3, RPS6KA1, AKT1, APLP2, POR, SFRP2, SPINT1, SLPI, SERPING1, NAIP, C3, SFN, A2M, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, VIL1, CD27, TNFAIP8, SERPINA1, ARRB1, ARRB2, TIMP2, TIMP3, TIMP1, CR1, SERPINB2, GPX1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, BIRC5, BIRC2, LTF, BIRC3, SERPINB10, CSTA, LEF1, IFI6, NLRC4, PTGS2, CST7, THBS1, CST3, SPOCK2, SPOCK3, SNCA, KLF4, FABP1]
GO:0014911;positive regulation of smooth muscle cell migration;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;201.77833622021802;6.280566066213989;0.0067533393245778365;0.6961884407023742;[PDGFRB, DOCK5, NRP1, DOCK4, POSTN, IGFBP5, IGF1, AIF1, P2RY6, PAK1, NR4A3, RPS6KB1, CCL5, PDGFD, BCL2, NOX4]
GO:0051902;negative regulation of mitochondrial depolarization;8.0;1.0;0.875;9.628524252492122;107.5075323722012;7.8311634786251565;0.003598180358000013;0.7754860644832351;[IFI6, BCL2]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[HDAC2, PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:0032469;endoplasmic reticulum calcium ion homeostasis;10.0;0.8259837884571596;0.8282329060895002;9.52844079393514;288.6919123283276;6.686031174322154;0.009662258499776054;0.7571649570480019;[CAMK2D, WFS1, PML, BCL2, GRINA, TGM2]
GO:0033033;negative regulation of myeloid cell apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.360260265897443;105.01969455662797;7.069023426578259;0.003514914665221449;0.7365101867784198;[GHSR, FCER1G, CCL5, CXCR2, CLEC5A, IRF7, BCL2, MIF, NOD2, CCR5]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[SPI1, SPIB, MNX1, MEF2A, MEF2C, PADI4, ATF3, CDCA7, GATA3, GATA1, HESX1, MCTS1, JUN, HACE1, EIF2AK2, NR2F2, EZH2, HOXC10, CHAF1B, ACTL6A, FOS, SIRT1, PLSCR1, STAT4, FLNA, ZNF467, CASP8AP2, STAT1, ATAD2, PKN1, CCNT2, RUVBL2, RUVBL1, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CIITA, FHL2, FASLG, ARRB1, ARRB2, FOXM1, HHEX, BIRC5, BIRC2, UHRF1, ZBTB41, E2F1, E2F5, E2F7, E2F8, PRRX1, POU2AF1, CCNH, IKZF1, UXT, HNF1B, EREG, BTK, ZNF700, EGR1, EGR2, EGR3, ID1, SUV39H2, SUV39H1, BRCA1, BMI1, DEPDC1, SATB2, RELB, IL33, FOXA3, FOXA2, ETS1, LOXL2, EOMES, TCF7, LPXN, HMGA1, MXD1, PHTF2, HMGB2, AFF3, LYL1, NUP62, MYBL2, MYBL1, MYOCD, NCBP2, ETV1, ELF3, IRF7, IRF8, ZMYND11, CREB5, TAF9, TBX21, MAPK14, MAPK13, TAF5, NAA15, EHF, PHB2, HOXA9, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, HOXA4, MED1, PRKCB, HOXB9, HOXB4, HOXB3, HOXB2, HOXB7, HOXB6, HOXB5, ASF1B, RAD21, PRDM16, NKX2-3, NFE2, FOSL2, FOSL1, SNAI2, BTG2, TGFB1I1, ZNF367, TCF19, BRD2, HELLS, PAWR, PAX5, PAX2, AES, ZEB1, TAL1, ASCL2, GTF2H1, POU4F1, FOSB, MEN1, TLE4, DNMT1, AEBP1, NACC2, MAP2K6, HOPX, COPS5, MAFB, BCL6, CNOT3, MAFF, BCL3, LBH, RFC1, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, ABLIM3, POLR2E, ZNF503, POLR2I, POLR2J, POLR2K, POLR2L, IRX3, KLF4, PML, KLF1, KLF8, KLF6, KLF5, MNDA, GFI1, ZNF608, DPF3, SOX7, SOX4, EBF1, TXK, TWIST1, NHLH2, BCL11B, BCL11A, CBFA2T3, MDFIC, TFEC, SP100, PURA, APBB1, CDX2, CDX1, GRHL2, TRIP13, ARID4A, ARID4B, HOXA11, HOXA10, CHCHD3, PTTG1, LMO2, COL4A2, TIMELESS, C5AR1, NLRP3, CBX4, NR4A2, FEV, CREBZF, KDM5D, KLF12, KLF13, LTF, LEF1, HLX, MEIS2, MEIS1, RBMX]
GO:1903078;positive regulation of protein localization to plasma membrane;8.0;0.8436909121759173;0.7968454560879586;9.434368238051164;218.50214452761784;5.845247994956144;0.00731307013817619;0.6739262542938873;[LRP1, TREM2, AKT1, EPHB2, PLS1, PRKCH, PRKCE, RHOG, SORBS1, VIL1, IFNG, EPHA3, EPHA2]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[PPP2R1A, CDC25C, CDC25A, PTPRE, PTPRC, BCL2, PTPRR, PTPN22, PTPRK, DUSP10, DLGAP5, DUSP2, PPP1R12A, DUSP3, DUSP1, DUSP6, LCK, PPP1R15A, TPTE, CPPED1, PPP1CA, PTPN6, PTPN7, PTPN4, CDKN3]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB2, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, SH2D2A, TXK, TGFA, PDGFA, PIK3R3, SLC30A10, PRKCZ, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PILRA, IGF1, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, GAB2, VAV1, HCK, KIT, PLCB1, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF1, SULF2, NCF1, NCF2, NCF4, SLA, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, MATK, TSC2, CYBB, PDGFRL, DOK2, COL4A2, CD8B, KIF16B, COL4A1, CD8A, BLK, CSF1R, CUL5, RASGRP4, FOXO1, SOCS2, STAP1, TGFB1, CAV2, CRIM1, BMX, VIL1, GH1, NR4A3, FES, CSPG4, ITGB3, PIK3C2A, GHR, BLNK, NCBP2, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, SHCBP1, CD4, CD7, TEK]
GO:0007202;activation of phospholipase C activity;9.0;1.0;0.896240625180289;9.628524252492122;83.73920694944017;6.444869117505266;0.0028026758962043192;0.7258315315665724;[ITK, TXK, C5AR1, AVPR1A, SELE, RASGRP4, EDNRA, GNA15, GNAQ, PLCG1]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[IL1RN, ADM, PRL, ETS1, THBD, CD38, TGFB1, IGFBP5, CAD, FOS, FOSL1, ADCYAP1, CLDN4, PNOC, RARA, BCL2, FOSB]
GO:0022898;regulation of transmembrane transporter activity;6.0;0.5295311121456219;0.5878858686629554;7.417506353023566;24.765424706708153;4.321752512322768;8.288764774983087E-4;0.5441349370523758;[, FMR1, EPHB2, MEF2C, DAPK1, PRKCE, ACTN4, ATP1B2, PDZK1, ATP1B1, GEM, CFTR, KCNE3, TWIST1, NEDD4L, ADRB2, PLCG2, DRD4, CAV1, EHD3, FXYD2, BCL2, FXYD6, CALM3, CTSS, GRM5, JPH2, PDE4B, YWHAH, GPR35, PDE4D, MMP9, DNM2, SHANK3, NLGN1, CAMK2D, PTAFR, PLN, DMD, NEDD4, FKBP1B, GOPC]
GO:1903514;release of sequestered calcium ion into cytosol by endoplasmic reticulum;15.0;0.9326813400603323;0.9547019944812309;9.607904965289386;524.5434794588007;7.697632086000634;0.017555998199003178;0.8820185873056371;[FKBP1B, FASLG, CCR5]
GO:0048743;positive regulation of skeletal muscle fiber development;9.0;1.0;0.896240625180289;9.628524252492122;623.8299612915386;7.697632086000634;0.02087902739391249;0.7898978880348613;[BCL2]
GO:0045636;positive regulation of melanocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.503361109538115;190.69673191605972;8.390779266560578;0.006382448001314043;0.7800242071602487;[BCL2, ADAMTS20]
GO:0007569;cell aging;3.0;0.7980440201809971;0.597142322680643;8.935377071932177;24.751975343904395;5.618190544320798;8.284263394289076E-4;0.485434838299289;[CDKN1A, SERPINE1, BRCA2, ICAM1, NUP62, CHEK1, MME, PRKCD, H2AFX, HMGA1, MIF, MAPK14, SIRT1, PML, DNAJA3, CDK1, BCL2, NOX4, ENG]
GO:0045086;positive regulation of interleukin-2 biosynthetic process;8.0;1.0;0.875;9.628524252492122;834.8798377098682;7.292166977892469;0.027942676825076673;0.747921758369865;[CD86, IL1A, CD4, CD80, IL1B, CD28, PRKCQ, CD3E, CARD11]
GO:0030318;melanocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;22.857985252022832;6.8867018697843045;7.650361955340501E-4;0.6424272657460779;[MEF2C, EDNRB, KIT, BCL2]
GO:0048599;oocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;72.7828096339012;7.292166977892469;0.0024359751381706407;0.6631627702307852;[BCL2]
GO:0048753;pigment granule organization;5.0;0.8436909121759173;0.712086467948879;9.223059144383958;20.915744831851537;6.518977089658987;7.000311565738116E-4;0.623621803389518;[RAB32, BCL2]
GO:0006509;membrane protein ectodomain proteolysis;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;50.748517158788495;6.781341354126479;0.0016985071986044009;0.6977174774718518;[PSEN2, ADAM9, PRTN3, PRKCQ, RBMX]
GO:0048873;homeostasis of number of cells within a tissue;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;26.75021374699733;6.444869117505266;8.953055804826206E-4;0.6527112189764278;[F2R, FLT3LG, CORO1A, GATA1, BCL2, CCR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, PGLYRP1, RNASE6, RNASE3, MIF, HLA-E, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, PRKDC, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, SIGLEC16, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, RIPK2, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, RELB, IGKC, CARD9, NR1H4, KIR3DL1, F2RL1, LGR4, C1QC, FCN1, NCF1, NCF2, SLA, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, PSTPIP1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0032212;positive regulation of telomere maintenance via telomerase;10.0;1.0;0.9152410118609203;9.628524252492122;1624.1830741800397;6.250713103064308;0.054359945822938814;0.734902770639515;[AURKB, NEK2, CCT8, CCT7, CCT5, CCT4, CCT3, CCT2, NEK7, CCT6A, PRKCQ]
GO:0030032;lamellipodium assembly;6.0;0.8933024483968273;0.7697715367885581;9.533214072687796;78.21732158183345;6.311337724880743;0.002617863362324714;0.6458824173477649;[CYFIP1, PARVB, ABLIM1, ABLIM3, NUP85, KIT, VCL, WASF3, SH2B1]
GO:0030279;negative regulation of ossification;5.0;0.8436909121759173;0.712086467948879;9.377209824211215;41.83246312675316;5.500407508664414;0.0014000948940798496;0.571532107649126;[CALCA, ECM1, TWIST1, TNF, GATA1, HOXA2, MEN1, CCR1, MEF2C, TGFB1, IGFBP5, TMEM64, AXIN2, GREM1, CDK6, ID1, BCL2]
